We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+5.85%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.37B
AUM Growth
+$218M
Cap. Flow
+$142M
Cap. Flow %
5.96%
Top 10 Hldgs %
34.53%
Holding
463
New
51
Increased
101
Reduced
189
Closed
15

Top Buys

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$15.1M
2
BA icon
Boeing
BA
+$14.5M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$13.2M
4
ORBC
ORBCOMM, Inc.
ORBC
+$12.3M
5
AAPL icon
Apple
AAPL
+$12.3M

Top Sells

Rank Stock Value
1
OMER icon
Omeros
OMER
+$7.82M
2
T icon
AT&T
T
+$6.06M
3
GIII icon
G-III Apparel Group
GIII
+$4.1M
4
RIG icon
Transocean
RIG
+$3.47M
5
PXD
Pioneer Natural Resource Co.
PXD
+$3.16M

Sector Composition

Rank Sector Weight
1 Healthcare 19.37%
2 Energy 18.91%
3 Financials 11.48%
4 Industrials 10.98%
5 Technology 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
51
AT&T
T
$153B
$12.3M 0.52%
483,935
-247,362
-34% -$6.06M
BMY icon
52
Bristol-Myers Squibb
BMY
$123B
$12.3M 0.52%
197,587
-743
-0.4% -$44.1K
C icon
53
Citigroup
C
$216B
$12.1M 0.51%
168,388
-667
-0.4% -$47.2K
MED icon
54
Medifast
MED
$115M
$12M 0.5%
53,957
-10,605
-16% -$2.15M
UNP icon
55
Union Pacific
UNP
$176B
$11.8M 0.5%
72,580
-183
-0.3% -$27.5K
PEP icon
56
PepsiCo
PEP
$185B
$11.7M 0.49%
104,684
-567
-0.5% -$64.2K
WFC icon
57
Wells Fargo
WFC
$261B
$11.4M 0.48%
217,677
-220
-0.1% -$12.6K
EMR icon
58
Emerson Electric
EMR
$76.5B
$11.4M 0.48%
149,344
-1,061
-0.7% -$78.3K
ABBV icon
59
AbbVie
ABBV
$448B
$11M 0.46%
116,264
-1,164
-1% -$110K
DCO icon
60
Ducommun
DCO
$2.54B
$10.6M 0.45%
259,297
-7,489
-3% -$280K
GILD icon
61
Gilead Sciences
GILD
$165B
$10.5M 0.44%
135,574
-575
-0.4% -$43.4K
F icon
62
Ford
F
$55.7B
$10.4M 0.44%
1,126,173
-50,075
-4% -$501K
UHAL icon
63
U-Haul Holding Co
UHAL
$13.9B
$10.3M 0.43%
289,180
+430
+0.1% +$15.9K
CELG
64
DELISTED
Celgene Corp
CELG
$9.74M 0.41%
108,858
-24,652
-18% -$2.18M
DRRX
65
DELISTED
DURECT Corp
DRRX
$9.59M 0.4%
871,890
+7,070
+0.8% +$96.1K
NVDA icon
66
NVIDIA
NVDA
$4.92T
$9.11M 0.38%
1,296,440
+1,106,040
+581% +$7.19M
CL icon
67
Colgate-Palmolive
CL
$73.6B
$9.09M 0.38%
135,733
-2,448
-2% -$163K
WRLD icon
68
World Acceptance Corp
WRLD
$872M
$8.79M 0.37%
76,878
-2
-0% -$229
SUPN icon
69
Supernus Pharmaceuticals
SUPN
$2.75B
$8.62M 0.36%
171,188
– –
CPRT icon
70
Copart
CPRT
$25.5B
$8.17M 0.34%
634,408
-25,520
-4% -$381K
DD icon
71
DuPont de Nemours
DD
$18.3B
$8.15M 0.34%
50,044
+6,379
+15% +$1.1M
TFC icon
72
Truist Financial
TFC
$62.3B
$8.08M 0.34%
166,536
-1,903
-1% -$97.7K
INTC icon
73
Intel
INTC
$488B
$7.83M 0.33%
165,540
-799
-0.5% -$38.9K
WMT icon
74
Walmart Inc
WMT
$893B
$7.43M 0.31%
237,294
+189,144
+393% +$5.79M
ICE icon
75
Intercontinental Exchange
ICE
$80.1B
$7.29M 0.31%
97,325
-860
-0.9% -$64.7K
1 2
3
4 5

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SL
Summitry LLC Foster City, California $2.83B AUM 17.32% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $2.82B AUM 13.66% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $2.84B AUM 30.75% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $2.85B AUM

Ingalls & Snyder LLC's Q3 2018 Portfolio in Review

As of Q3 2018, Ingalls & Snyder LLC held 463 positions worth $2.37B, up 10% from $2.15B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ingalls & Snyder LLC deployed $142M of net new capital in Q3 2018, opening 51 new positions and adding to 101 existing holdings. Its largest new stake was ORBCOMM, Inc.: 1,167,077 shares worth $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Energy and Financials.

On the sell side, the largest reduction was Omeros, an estimated $7.82M trimmed.

  • Ingalls & Snyder LLC's largest Q3 2018 buy was ORBCOMM, Inc.: 1,167,077 shares worth $12.7M.
  • Ingalls & Snyder LLC added most to Corcept Therapeutics in Q3 2018, an estimated $15.1M increase.
  • Ingalls & Snyder LLC's biggest Q3 2018 reduction was Omeros, cutting an estimated $7.82M.
  • Ingalls & Snyder LLC fully exited G-III Apparel Group in Q3 2018, selling an estimated $4.1M.
  • Ingalls & Snyder LLC's ten largest holdings make up 35% of its $2.37B portfolio in Q3 2018.
  • Ingalls & Snyder LLC opened 51 new positions and closed 15 in Q3 2018.
  • Ingalls & Snyder LLC's portfolio value rose 10% quarter-over-quarter to $2.37B.

Based on Ingalls & Snyder LLC's 13F filing for Q3 2018, filed 24 Oct 2018.